麥肯錫公司新出的報告《中國創新》Gauging the strength of Chinese innovation 裏面提到中國的乙型病毒性肝炎和脂肪肝患病率近美國的7倍。報告中指出當前中國有9000萬慢性 乙肝患者,其中有2800萬人需要治療,將近700萬人因嚴重肝臟疾病和癌症發病風險需要緊急治療、中國慢性丙肝患者感染約為1000萬人,其中250萬急需治療。
Japanese Patented Technology 99.7% eco-Protect Ingredients Made from 99.7% purified water and 0.24% food grade potassium carbonate with Japanese patented technology. Green product, no alcohol, no chemical residue. Kills Germs up to 99.999% STC tested and certified that the product can effectively kill following bacteria and virus, with an efficacy rate up to 99.999%: Escherichia coli, Klebsiella pneumonia, Staphylococcus aureus, Legionella pneumophila, Salmonella, H1N1